Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-12-007596)

Filing Details

Accession Number:: 0001179110-12-007596
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-05-02 19:01:40
Reporting Period:: 2012-05-01

Filing Date:: 2012-05-02
Accepted Time:: 2012-05-02 19:01:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1080014	Theravance Inc	THRX	Pharmaceutical Preparations (2834)	943265960

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1032623	M Jeffrey Drazan	Bertram Capital 800 Concar Drive, Suite 100 San Mateo CA 94402		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-05-01	8,586	$21.71	33,465	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This transaction was executed in multiple trades at prices from $21.35 to $21.98. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.